Announcements Trials
Browse Landscape

Status

Completed 4Unknown 1Terminated 1Recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 75Observational 4

Sponsor

Cancer Type

Dermatologic 4

Conditions

Keratosis, Actinic 3Keratosis 1Carcinoma, Basal Cell 1

Interventions

Surveys and Questionnaires 286Blood Specimen Collection 145Gene Expression Profiling 96Interviews as Topic 83Immunohistochemistry 78Polymerase Chain Reaction 64Surgical Procedures, Operative 62Magnetic Resonance Spectroscopy 58Microarray Analysis 55Flow Cytometry 53Radiotherapy 49Amplified Fragment Length Polymorphism Analysis 48Drug Therapy 46Observation 45Biopsy 42Reverse Transcriptase Polymerase Chain Reaction 39Bevacizumab 39Data Collection 35Sorafenib 29Psychiatric Rehabilitation 29Nivolumab 28palbociclib 26In Situ Hybridization, Fluorescence 26Rituximab 25Therapeutics 24Neoadjuvant Therapy 24Hepatectomy 24Docetaxel 24Colonoscopy 24Sunitinib 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Observational × Imiquimod × Clear all
NCT00189254 2022-02-07

A Study to Follow up Recurrence Rates of Actinic Keratoses One Year After Completion of Study 1487-IMIQ

Viatris Inc.

Completed
72 enrolled
Dermatologic

Keratosis, Actinic

NCT02362152 2019-12-13

RAPID-ACT

LEO Pharma

Completed
1,168 enrolled
Dermatologic

Keratosis, Actinic

NCT01212562 2011-09-02

IMCX

University of Ioannina

Completed
70 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT00114023 2007-02-19

1-Year Follow up to the 1473-IMIQ Study

Graceway Pharmaceuticals, LLC

Completed
84 enrolled
Dermatologic

Keratosis, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡